🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10364+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10364 recruiting trials

Phase 3RecruitingNCT07039916

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

🏥 Immunovant Sciences GmbH📍 75 sites📅 Started May 2025View details ↗
Phase 2, PHASE3RecruitingNCT06873334

Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease

👨‍⚕️ Masoud Mokhtarani, MD, Skyhawk Therapeutics, Inc.📍 11 sites📅 Started May 2025View details ↗
RecruitingNCT07496242

Immunological Phenotype of Desmoid-fibromatosis-affected Patients.

👨‍⚕️ Chiara Colombo, MD, Surgical Oncologist, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano📍 8 sites📅 Started May 2025View details ↗
Phase 2RecruitingNCT06932757

Adjuvant Quisinostat in High-Risk Uveal Melanoma

👨‍⚕️ Jose Lutzky, MD, University of Miami📍 1 site📅 Started May 2025View details ↗
NARecruitingNCT07062744

The Role of Swan-Ganz Catheter in Hemodynamic Resuscitation for Patients With Cardiogenic Shock

👨‍⚕️ Thang Xuan Pham, MD, PhD Candidate, Hanoi Medical University📍 1 site📅 Started May 2025View details ↗
Phase 2RecruitingNCT06846463

Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+

👨‍⚕️ Bruce Hough, MD, Virginia Commonwealth University📍 1 site📅 Started May 2025View details ↗
RecruitingNCT06978660

Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis

👨‍⚕️ Pablo García Pavía, MD, PhD, Hospital Universitario Puerta de Hierro📍 10 sites📅 Started May 2025View details ↗
RecruitingNCT06780475

Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Cutaneous Merkel Cell Carcinoma

👨‍⚕️ Astrid Blom, MD, Dermato-oncology Department, Ambroise Paré Hospital, APHP📍 1 site📅 Started May 2025View details ↗
Phase 3RecruitingNCT06971094

Safety and Efficacy Evaluation of GC101 Gene Therapy Via Intrathecal (IT) Injectionin the Treatment of Patients With Type 2 Spinal Muscular Atrophy (SMA) - Phase III

👨‍⚕️ GeneCradle, Inc China📍 7 sites📅 Started May 2025View details ↗
Phase 1, PHASE2RecruitingNCT06966154

A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL

🏥 Fudan University📍 1 site📅 Started May 2025View details ↗
Phase 1RecruitingNCT07072169

A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (B-NHL)

👨‍⚕️ Wei li Zhao, Ruijin Hospital📍 1 site📅 Started May 2025View details ↗
Phase 1RecruitingNCT07065409

Treatment of Moyamoya Disease With iPSC-derived Exosomes

👨‍⚕️ Huaqiu Zhang, Tongji Hospital📍 1 site📅 Started May 2025View details ↗
Phase 3RecruitingNCT06502990

Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy

🏥 Amryt Pharma📍 12 sites📅 Started May 2025View details ↗
Phase 3RecruitingNCT05815927

Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer

👨‍⚕️ Panagiotis Belermpas, MD, University of Zurich📍 26 sites📅 Started May 2025View details ↗
Phase 1RecruitingNCT07021703

A Clinical Trial of Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried

🏥 Ningbo Rongan Biological Pharmaceutical Co., Ltd.📍 1 site📅 Started May 2025View details ↗
RecruitingNCT05837221

Microbiome in Head and Neck Squamous Cell Carcinoma

👨‍⚕️ Shi-Long E Lu, MD, PhD, University of Colorado, Denver📍 1 site📅 Started May 2025View details ↗
RecruitingNCT06941025

Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding

🏥 Chiesi Farmaceutici S.p.A.📍 5 sites📅 Started May 2025View details ↗
RecruitingNCT06486428

Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies

👨‍⚕️ Christine Lovly, MD PhD, Vanderbilt-Ingram Cancer Center, Nashville, TN📍 52 sites📅 Started May 2025View details ↗
Phase 1RecruitingNCT06942143

An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors

🏥 Guangzhou FineImmune Biotechnology Co., LTD.📍 1 site📅 Started May 2025View details ↗
Phase 2RecruitingNCT07023484

Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer

👨‍⚕️ Ka Yu Tse, MBBS, MMedSc, PhD, FRCOG, The University of Hong Kong📍 6 sites📅 Started May 2025View details ↗
← PreviousPage 107 of 519Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →